Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?

Gorringe AR.

Expert Rev Vaccines. 2005 Jun;4(3):373-9. Review.

PMID:
16026250
2.

Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

Finney M, Vaughan T, Taylor S, Hudson MJ, Pratt C, Wheeler JX, Vipond C, Feavers I, Jones C, Findlow J, Borrow R, Gorringe A.

Hum Vaccin. 2008 Jan-Feb;4(1):23-30.

PMID:
17921703
3.

The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

Gorringe A, Halliwell D, Matheson M, Reddin K, Finney M, Hudson M.

Vaccine. 2005 Mar 18;23(17-18):2210-3.

PMID:
15755597
4.

Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

Gorringe AR, Taylor S, Brookes C, Matheson M, Finney M, Kerr M, Hudson M, Findlow J, Borrow R, Andrews N, Kafatos G, Evans CM, Read RC.

Clin Vaccine Immunol. 2009 Aug;16(8):1113-20. doi: 10.1128/CVI.00118-09.

5.

Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.

Vaughan TE, Skipp PJ, O'Connor CD, Hudson MJ, Vipond R, Elmore MJ, Gorringe AR.

Vaccine. 2006 Jun 19;24(25):5277-93.

PMID:
16682101
6.

Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.

Li Y, Zhang Q, Winterbotham M, Mowe E, Gorringe A, Tang CM.

Infect Immun. 2006 Nov;74(11):6348-55.

8.

Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.

Braun JM, Beuth J, Blackwell CC, Giersen S, Higgins PG, Tzanakaki G, Unverhau H, Weir DM.

Vaccine. 2004 Feb 17;22(7):898-908.

PMID:
15040943
9.

Rapid characterization of outer-membrane proteins in Neisseria lactamica by SELDI-TOF-MS (surface-enhanced laser desorption ionization-time-of-flight MS) for use in a meningococcal vaccine.

Mukhopadhyay TK, Halliwell D, O'Dwyer C, Shamlou PA, Levy MS, Allison N, Gorringe A, Reddin KM.

Biotechnol Appl Biochem. 2005 Apr;41(Pt 2):175-82.

PMID:
15315478
10.

In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica.

Sánchez S, Troncoso G, Criado MT, Ferreirós C.

Vaccine. 2002 Jul 26;20(23-24):2957-63.

PMID:
12126908
11.

Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study.

Deasy AM, Guccione E, Dale AP, Andrews N, Evans CM, Bennett JS, Bratcher HB, Maiden MC, Gorringe AR, Read RC.

Clin Infect Dis. 2015 May 15;60(10):1512-20. doi: 10.1093/cid/civ098.

PMID:
25814628
12.

Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica.

Kremastinou J, Tzanakaki G, Pagalis A, Theodondou M, Weir DM, Blackwell CC.

FEMS Immunol Med Microbiol. 1999 May;24(1):73-8.

13.
14.

Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece.

Kremastinou J, Tzanakaki G, Levidiotou S, Markou F, Themeli E, Voyiatzi A, Psoma E, Theodoridou M, Blackwell CC.

FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):23-9.

15.

Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica.

Lucidarme J, Gilchrist S, Newbold LS, Gray SJ, Kaczmarski EB, Richardson L, Bennett JS, Maiden MC, Findlow J, Borrow R.

Clin Vaccine Immunol. 2013 Sep;20(9):1360-9. doi: 10.1128/CVI.00090-13.

16.

Assessment of vaccine potential of the Neisseria-specific protein NMB0938.

Sardiñas G, Climent Y, Rodríguez Y, González S, García D, Cobas K, Caballero E, Pérez Y, Brookes C, Taylor S, Gorringe A, Delgado M, Pajón R, Yero D.

Vaccine. 2009 Nov 16;27(49):6910-7. doi: 10.1016/j.vaccine.2009.09.005.

PMID:
19751688
17.

Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.

Litt DJ, Savino S, Beddek A, Comanducci M, Sandiford C, Stevens J, Levin M, Ison C, Pizza M, Rappuoli R, Kroll JS.

J Infect Dis. 2004 Oct 15;190(8):1488-97.

PMID:
15378443
18.

Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis.

Troncoso G, Sánchez S, Criado MT, Ferreirós CM.

FEMS Immunol Med Microbiol. 2002 Sep 6;34(1):9-15.

19.

Vaccines against meningococcal disease: current and future technologies.

Riddell A, Buttery J.

Expert Opin Biol Ther. 2001 May;1(3):385-99. Review.

PMID:
11727513
20.

Meningococcal disease: a review on available vaccines and vaccines in development.

Bröker M, Fantoni S.

Minerva Med. 2007 Oct;98(5):575-89. Review.

PMID:
18043565

Supplemental Content

Support Center